
PTIX
USDProtagenic Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$2.220
Máximo
$2.290
Mínimo
$2.140
Volumen
0.03M
Fundamentos de la Empresa
Capitalización de Mercado
4.1M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.71M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
Delay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company developing novel neuro-active
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company
Acciones Relacionadas
CXT
Crane NXT Co.
VOXX
VOXX International Corporation
ADGM
Adagio Medical Holdings Inc
HPF
John Hancock Pfd Income Fund II Pfd Income Fund II
SNCRL
Synchronoss Technologies Inc. 8.375% Senior Notes due 2026
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.